Pancreatic agenesis 1 is an autosomal recessive disorder caused by mutations of the PDX1 gene. Besides the exocrine pancreatic dysfunction a neonatal diabetes is found in these patients.
Pancreatogenic diabetes | ||||
Mitchell-Riley syndrome | ||||
Pancreatic agenesis 1 | ||||
PDX1 | ||||
Pancreatic agenesis 2 | ||||
Pancreatic agenesis and congenital heart defects | ||||
1. |
Odievre M et al. (1975) [Fructose 1,6-diphosphatase deficiency in 2 sisters]. |
2. |
Moses SW et al. (1991) Fructose-1,6-diphosphatase deficiency in Israel. |
3. |
Bührdel P et al. (1990) Biochemical and clinical observations in four patients with fructose-1,6-diphosphatase deficiency. |
4. |
Baker L et al. (1970) Fasting hypoglycaemia and metabolic acidosis associated with deficiency of hepatic fructose-1,6-diphosphatase activity. |
5. |
Sia CL et al. (1969) Studies on the subunit structure of rabbit liver fructose diphosphatase. |
6. |
Melancon SB et al. (1972) Detection of fructose-6,-diphosphatase deficiency with use of white blood cells. |
7. |
Baerlocher K et al. (1971) Infantile lactic acidosis due to hereditary fructose 1,6-diphosphatase deficiency. |
8. |
Pagliara AS et al. (1972) Hepatic fructose-1,6-diphosphatase deficiency. A cause of lactic acidosis and hypoglycemia in infancy. |
9. |
Greene HL et al. (1972) "Ketotic hypoglycemia" due to hepatic fructose-1,6-diphosphatase deficiency: treatment with folic acid. |
11. |
Kikawa Y et al. (1995) Identification of a genetic mutation in a family with fructose-1,6- bisphosphatase deficiency. |
12. |
Besley GT et al. (1994) Fructose-1,6-bisphosphatase deficiency: severe phenotype with normal leukocyte enzyme activity. |
13. |
Rothschild CB et al. (1995) Fructose-1,6-bisphosphatase: genetic and physical mapping to human chromosome 9q22.3 and evaluation in non-insulin-dependent diabetes mellitus. |
14. |
Kikawa Y et al. (1997) Identification of genetic mutations in Japanese patients with fructose-1,6-bisphosphatase deficiency. |
15. |
Tillmann H et al. (1998) Isolation and characterization of an allelic cDNA for human muscle fructose-1,6-bisphosphatase. |
16. |
Berge KE et al. (2000) Accumulation of dietary cholesterol in sitosterolemia caused by mutations in adjacent ABC transporters. |
17. |
Lee MH et al. (2001) Identification of a gene, ABCG5, important in the regulation of dietary cholesterol absorption. |
19. |
Repa JJ et al. (2002) Regulation of ATP-binding cassette sterol transporters ABCG5 and ABCG8 by the liver X receptors alpha and beta. |
20. |
Lu K et al. (2002) Molecular cloning, genomic organization, genetic variations, and characterization of murine sterolin genes Abcg5 and Abcg8. |
21. |
Matsuura T et al. (2002) Two newly identified genomic mutations in a Japanese female patient with fructose-1,6-bisphosphatase (FBPase) deficiency. |
22. |
Yu L et al. (2002) Disruption of Abcg5 and Abcg8 in mice reveals their crucial role in biliary cholesterol secretion. |
23. |
Sehayek E et al. (2002) Loci on chromosomes 14 and 2, distinct from ABCG5/ABCG8, regulate plasma plant sterol levels in a C57BL/6J x CASA/Rk intercross. |
24. |
None (2003) Role of ABC transporters in secretion of cholesterol from liver into bile. |
25. |
Yang C et al. (2004) Disruption of cholesterol homeostasis by plant sterols. |
26. |
Rees DC et al. (2005) Stomatocytic haemolysis and macrothrombocytopenia (Mediterranean stomatocytosis/macrothrombocytopenia) is the haematological presentation of phytosterolaemia. |
27. |
Mannucci L et al. (2007) Beta-sitosterolaemia: a new nonsense mutation in the ABCG5 gene. |
28. |
Rios J et al. (2010) Identification by whole-genome resequencing of gene defect responsible for severe hypercholesterolemia. |
29. |
Li B et al. (2014) Fructose-1,6-bisphosphatase opposes renal carcinoma progression. |
30. |
Tosi R et al. (1978) Immunological dissection of human Ia molecules. |
31. |
Duquesnoy RJ et al. (1979) Identification of an HLA-DR-associated system of B-cell alloantigens. |
32. |
Todd JA et al. (1990) The A3 allele of the HLA-DQA1 locus is associated with susceptibility to type 1 diabetes in Japanese. |
33. |
Helmuth R et al. (1990) HLA-DQ alpha allele and genotype frequencies in various human populations, determined by using enzymatic amplification and oligonucleotide probes. |
34. |
Briata P et al. (1989) Alternative splicing of HLA-DQB transcripts and secretion of HLA-DQ beta-chain proteins: allelic polymorphism in splicing and polyadenylylation sites. |
35. |
Del Pozzo G et al. (1989) Mummy DNA fragment identified. |
36. |
Kwok WW et al. (1989) Mutational analysis of the HLA-DQ3.2 insulin-dependent diabetes mellitus susceptibility gene. |
37. |
Gyllensten UB et al. (1988) Generation of single-stranded DNA by the polymerase chain reaction and its application to direct sequencing of the HLA-DQA locus. |
38. |
Todd JA et al. () HLA-DQ beta gene contributes to susceptibility and resistance to insulin-dependent diabetes mellitus. |
39. |
Okada K et al. (1985) Gene organization of DC and DX subregions of the human major histocompatibility complex. |
40. |
Moriuchi J et al. (1985) Nucleotide sequence of an HLA-DQ alpha chain derived from a DRw9 cell line: genetic and evolutionary implications. |
41. |
None () Molecular cloning of Ancient Egyptian mummy DNA. |
42. |
Nadler LM et al. (1981) Monoclonal antibody identifies a new Ia-like (p29,34) polymorphic system linked to the HLA-D/DR region. |
43. |
None (1981) Role of MHC gene products in immune regulation. |
44. |
Corte G et al. (1981) Human Ia molecules carrying DC1 determinants differ in both alpha- and beta-subunits from Ia molecules carrying DR determinants. |
45. |
Sorrentino R et al. (1983) Microfingerprinting analysis of human Ia molecules favours a three loci model. |
46. |
Cohen D et al. (1984) Class II HLA-DC beta-chain DNA restriction fragments differentiate among HLA-DR2 individuals in insulin-dependent diabetes and multiple sclerosis. |
47. |
Schenning L et al. (1984) Both alpha and beta chains of HLA-DC class II histocompatibility antigens display extensive polymorphism in their amino-terminal domains. |
48. |
Bono MR et al. (1982) Direct evidence of homology between human DC-1 antigen and murine I-A molecules. |
49. |
Hsu SH et al. (1981) Genetic control of major histocompatibility complex-linked immune responses to synthetic polypeptides in man. |
50. |
Auffray C et al. (1982) cDNA clone for the heavy chain of the human B cell alloantigen DC1: strong sequence homology to the HLA-DR heavy chain. |
51. |
Tanigaki N et al. (1980) Molecular identification of human Ia antigens coded for by a gene locus closely linked to HLA-DR locus. |
52. |
Accolla RS et al. (1981) Distinct forms of both alpha and beta subunits are present in the human Ia molecular pool. |
53. |
Shackelford DA et al. (1981) Human B-cell alloantigens DC1, MT1, and LB12 are identical to each other but distinct from the HLA-DR antigen. |
54. |
Meyer CG et al. (1994) HLA-D alleles associated with generalized disease, localized disease, and putative immunity in Onchocerca volvulus infection. |
55. |
Suzuki Y et al. (1996) Evidence for genetic regulation of susceptibility to toxoplasmic encephalitis in AIDS patients. |
56. |
Nabozny GH et. al. (1996) HLA-DQ8 transgenic mice are highly susceptible to collagen-induced arthritis: a novel model for human polyarthritis. |
57. |
Bradley DS et. al. (1997) HLA-DQB1 polymorphism determines incidence, onset, and severity of collagen-induced arthritis in transgenic mice. Implications in human rheumatoid arthritis. |
59. |
Wen L et al. (2000) In vivo evidence for the contribution of human histocompatibility leukocyte antigen (HLA)-DQ molecules to the development of diabetes. |
60. |
Lambert NC et al. (2000) Cutting edge: persistent fetal microchimerism in T lymphocytes is associated with HLA-DQA1*0501: implications in autoimmunity. |
61. |
Cucca F et al. (2001) A correlation between the relative predisposition of MHC class II alleles to type 1 diabetes and the structure of their proteins. |
62. |
Kim CY et al. (2004) Structural basis for HLA-DQ2-mediated presentation of gluten epitopes in celiac disease. |
63. |
Hovhannisyan Z et al. (2008) The role of HLA-DQ8 beta57 polymorphism in the anti-gluten T-cell response in coeliac disease. |
64. |
Stanescu HC et al. (2011) Risk HLA-DQA1 and PLA(2)R1 alleles in idiopathic membranous nephropathy. |
65. |
Chong JX et al. (2012) A population-based study of autosomal-recessive disease-causing mutations in a founder population. |
66. |
Paulus JM et al. (1978) Platelet formation in Mediterranean macrothrombocytosis. |
67. |
None (1975) Mediterranean macrothrombocytopenia. |
68. |
Shulman RS et al. (1976) Beta-sitosterolemia and xanthomatosis. |
69. |
Hatanaka I et al. (1990) Spinal cord compression with paraplegia in xanthomatosis due to normocholesterolemic sitosterolemia. |
70. |
Nguyen LB et al. (1990) A molecular defect in hepatic cholesterol biosynthesis in sitosterolemia with xanthomatosis. |
71. |
Beaty TH et al. (1986) Genetic analysis of plasma sitosterol, apoprotein B, and lipoproteins in a large Amish pedigree with sitosterolemia. |
72. |
Salen G et al. (1985) Increased plasma cholestanol and 5 alpha-saturated plant sterol derivatives in subjects with sitosterolemia and xanthomatosis. |
73. |
Skrede B et al. (1985) The presence of 5 alpha-sitostanol in the serum of a patient with phytosterolemia, and its biosynthesis from plant steroids in rats with bile fistula. |
74. |
Bhattacharyya AK et al. (1974) Beta-sitosterolemia and xanthomatosis. A newly described lipid storage disease in two sisters. |
75. |
Ducrou W et al. (1969) Stomatocytes, haemolytic anaemia and abdominal pain in Mediterranean migrants. Some examples of a new syndrome? |
76. |
Kwiterovich PO et al. (1981) Hyperapobetalipoproteinaemia in two families with xanthomas and phytosterolaemia. |
77. |
Brahimi S et al. (1984) Platelet count and mean platelet volume in an Algerian population indicating a low prevalence of Mediterranean macrothrombocytopenia. |
78. |
None (1980) Phytosterolaemia, xanthomatosis and premature atherosclerotic arterial disease: a case with high plant sterol absorption, impaired sterol elimination and low cholesterol synthesis. |
79. |
Wang C et al. (1981) A unique patient with coexisting cerebrotendinous xanthomatosis and beta-sitosterolemia. |
80. |
Salen G et al. (1996) Abnormal cholesterol biosynthesis in sitosterolaemia and the Smith-Lemli-Opitz syndrome. |
81. |
Patel SB et al. (1998) Mapping a gene involved in regulating dietary cholesterol absorption. The sitosterolemia locus is found at chromosome 2p21. |
82. |
Savoia A et al. (2001) Autosomal dominant macrothrombocytopenia in Italy is most frequently a type of heterozygous Bernard-Soulier syndrome. |
83. |
Lu K et al. (2001) High-resolution physical and transcript map of human chromosome 2p21 containing the sitosterolaemia locus. |
84. |
Lee MH et al. (2001) Fine mapping of a gene responsible for regulating dietary cholesterol absorption; founder effects underlie cases of phytosterolaemia in multiple communities. |
85. |
None (2003) Images in clinical medicine. Phytosterolemia and xanthomatosis. |
86. |
Solcà C et al. (2005) Sitosterolaemia in Switzerland: molecular genetics links the US Amish-Mennonites to their European roots. |
87. |
Stewart GW et al. (2006) Mediterranean stomatocytosis/macrothrombocytopenia: update from Adelaide, Australia. |
88. |
Buch S et al. (2007) A genome-wide association scan identifies the hepatic cholesterol transporter ABCG8 as a susceptibility factor for human gallstone disease. |
89. |
Stewart GW et al. (2008) Mediterranean macrothrombocytopenia and phytosterolaemia/sitosterolaemia. |
90. |
van den Ouweland JM et al. (1992) Mutation in mitochondrial tRNA(Leu)(UUR) gene in a large pedigree with maternally transmitted type II diabetes mellitus and deafness. |
91. |
Ballinger SW et al. (1992) Maternally transmitted diabetes and deafness associated with a 10.4 kb mitochondrial DNA deletion. |
92. |
Reardon W et al. (1992) Diabetes mellitus associated with a pathogenic point mutation in mitochondrial DNA. |
93. |
Alcolado JC et al. (1991) Importance of maternal history of non-insulin dependent diabetic patients. |
94. |
Sue CM et al. (1993) Mitochondrial gene mutations and diabetes mellitus. |
95. |
Ballinger SW et al. (1994) Mitochondrial diabetes revisited. |
96. |
Schulz JB et al. (1993) Mitochondrial gene mutations and diabetes mellitus. |
97. |
Velho G et al. (1996) Clinical phenotypes, insulin secretion, and insulin sensitivity in kindreds with maternally inherited diabetes and deafness due to mitochondrial tRNALeu(UUR) gene mutation. |
98. |
't Hart LM et al. (1996) Heteroplasmy levels of a mitochondrial gene mutation associated with diabetes mellitus decrease in leucocyte DNA upon aging. |
99. |
Vialettes BH et al. (1997) Phenotypic expression of diabetes secondary to a T14709C mutation of mitochondrial DNA. Comparison with MIDD syndrome (A3243G mutation): a case report. |
100. |
Kameoka K et al. (1998) Novel mitochondrial DNA mutation in tRNA(Lys) (8296A-->G) associated with diabetes. |
101. |
Martin Negrier ML et al. (1998) Partial triplication of mtDNA in maternally transmitted diabetes mellitus and deafness. |
102. |
Chinnery PF et al. (1999) Nonrandom tissue distribution of mutant mtDNA. |
103. |
Guillausseau PJ et al. (2001) Maternally inherited diabetes and deafness: a multicenter study. |
104. |
None (2001) Mitochondrial DNA mutations and diabetes: another step toward individualized medicine. |
105. |
Ogun O et al. (2012) Pearls & oy-sters: maternally inherited diabetes and deafness presenting with ptosis and macular pattern dystrophy. |
106. |
Wright NM et al. (1993) Permanent neonatal diabetes mellitus and pancreatic exocrine insufficiency resulting from congenital pancreatic agenesis. |
107. |
Stoffers DA et al. (1997) Pancreatic agenesis attributable to a single nucleotide deletion in the human IPF1 gene coding sequence. |
108. |
Schwitzgebel VM et al. (2003) Agenesis of human pancreas due to decreased half-life of insulin promoter factor 1. |
109. |
Maitra M et al. (2010) Identification of GATA6 sequence variants in patients with congenital heart defects. |
110. |
Lin X et al. (2010) A novel GATA6 mutation in patients with tetralogy of Fallot or atrial septal defect. |
111. |
Kodo K et al. (2009) GATA6 mutations cause human cardiac outflow tract defects by disrupting semaphorin-plexin signaling. |
112. |
Yorifuji T et al. (1994) Hereditary pancreatic hypoplasia, diabetes mellitus, and congenital heart disease: a new syndrome? |
113. |
Krapp A et al. (1996) The p48 DNA-binding subunit of transcription factor PTF1 is a new exocrine pancreas-specific basic helix-loop-helix protein. |
114. |
Suzuki E et al. (1996) The human GATA-6 gene: structure, chromosomal location, and regulation of expression by tissue-specific and mitogen-responsive signals. |
115. |
Morrisey EE et al. (1998) GATA6 regulates HNF4 and is required for differentiation of visceral endoderm in the mouse embryo. |
116. |
Krapp A et al. (1998) The bHLH protein PTF1-p48 is essential for the formation of the exocrine and the correct spatial organization of the endocrine pancreas. |
117. |
Hoveyda N et al. (1999) Neonatal diabetes mellitus and cerebellar hypoplasia/agenesis: report of a new recessive syndrome. |
118. |
Adell T et al. (2000) Role of the basic helix-loop-helix transcription factor p48 in the differentiation phenotype of exocrine pancreas cancer cells. |
119. |
Laitinen MP et al. (2000) Transcription factors GATA-4 and GATA-6 and a GATA family cofactor, FOG-2, are expressed in human ovary and sex cord-derived ovarian tumors. |
120. |
Rose SD et al. (2001) The role of PTF1-P48 in pancreatic acinar gene expression. |
121. |
Kawaguchi Y et al. (2002) The role of the transcriptional regulator Ptf1a in converting intestinal to pancreatic progenitors. |
122. |
Ketola I et al. (2003) Transcription factor GATA-6, cell proliferation, apoptosis, and apoptosis-related proteins Bcl-2 and Bax in human fetal testis. |
123. |
Sellick GS et al. (2003) A novel gene for neonatal diabetes maps to chromosome 10p12.1-p13. |
124. |
Sellick GS et al. (2004) Mutations in PTF1A cause pancreatic and cerebellar agenesis. |
125. |
Ho CK et al. (2005) Increased transcription and increased messenger ribonucleic acid (mRNA) stability contribute to increased GATA6 mRNA abundance in polycystic ovary syndrome theca cells. |
126. |
Lepore JJ et al. (2006) GATA-6 regulates semaphorin 3C and is required in cardiac neural crest for cardiovascular morphogenesis. |
127. |
Xin M et al. (2006) A threshold of GATA4 and GATA6 expression is required for cardiovascular development. |
128. |
Kamnasaran D et al. (2007) GATA6 is an astrocytoma tumor suppressor gene identified by gene trapping of mouse glioma model. |
129. |
Masui T et al. (2007) Early pancreatic development requires the vertebrate Suppressor of Hairless (RBPJ) in the PTF1 bHLH complex. |
130. |
Al-Shammari M et al. (2011) A novel PTF1A mutation in a patient with severe pancreatic and cerebellar involvement. |
131. |
Yorifuji T et al. (2012) Dominantly inherited diabetes mellitus caused by GATA6 haploinsufficiency: variable intrafamilial presentation. |
132. |
Weedon MN et al. (2014) Recessive mutations in a distal PTF1A enhancer cause isolated pancreatic agenesis. |
133. |
Yu L et al. (2014) Whole exome sequencing identifies de novo mutations in GATA6 associated with congenital diaphragmatic hernia. |
134. |
Rosas M et al. (2014) The transcription factor Gata6 links tissue macrophage phenotype and proliferative renewal. |
135. |
Lemons JA et al. (1979) Congenital absence of the pancreas and intrauterine growth retardation. |
136. |
Méhes K et al. (1976) Agenesis of pancreas and gall-bladder in an infant of incest. |
137. |
Winter WE et al. (1986) Congenital pancreatic hypoplasia: a syndrome of exocrine and endocrine pancreatic insufficiency. |
138. |
Dourov N et al. () [Agenesia of the pancreas. Anatomo-clinical observations of a case of diabetes mellitus, with steatorrhea and hypotrophy, in a newborn infant]. |
139. |
Howard CP et al. (1980) Long-term survival in a case of functional pancreatic agenesis. |
140. |
Widness JA et al. (1982) Permanent neonatal diabetes in an infant of an insulin-dependent mother. |
141. |
Wildling R et al. (1993) Agenesis of the dorsal pancreas in a woman with diabetes mellitus and in both of her sons. |
142. |
Stoffers DA et al. (1997) Early-onset type-II diabetes mellitus (MODY4) linked to IPF1. |
143. |
Thomas IH et al. (2009) Neonatal diabetes mellitus with pancreatic agenesis in an infant with homozygous IPF-1 Pro63fsX60 mutation. |
144. |
Nicolino M et al. (2010) A novel hypomorphic PDX1 mutation responsible for permanent neonatal diabetes with subclinical exocrine deficiency. |
145. |
Fajans SS et al. (2010) Obesity and hyperinsulinemia in a family with pancreatic agenesis and MODY caused by the IPF1 mutation Pro63fsX60. |
146. |
OMIM.ORG article Omim 260370 |